| Literature DB >> 35557678 |
Hassan Nageh1, Merna H Emam1, Fedaa Ali1, Nasra F Abdel Fattah2, Mohamed Taha3, Rehab Amin3,4, Elbadawy A Kamoun1,5, Samah A Loutfy1,2, Amal Kasry1.
Abstract
ZnO-NPs loaded polyvinylidene fluoride (PVDF) composite nanofibers were fabricated by electrospinning and optimized using different concentrations (0, 2, and 5 wt %) of ZnO-NPs. Characterization techniques, for example, FTIR, SEM, XRD, and tensile strength analysis were performed to analyze the composite nanofibers. Molecular docking calculations were performed to evaluate the binding affinity of PVDF and ZnO@PVDF against the hexon protein of adenovirus (PDB ID: 6CGV). The cytotoxicity of tested materials was evaluated using MTT assay, and nontoxic doses subjected to antiviral evaluation against human adenovirus type-5 as a human respiratory model were analyzed using quantitative polymerase chain reaction assay. IC50 values were obtained at concentrations of 0, 2, and 5% of ZnO-loaded PVDF; however, no cytotoxic effect was detected for the nanofibers. In 5% ZnO-loaded PVDF nanofibers, both the viral entry and its replication were inhibited in both the adsorption and virucidal antiviral mechanisms, making it a potent antiviral filter/mask. Therefore, ZnO-loaded PVDF nanofiber is a potentially prototyped filter embedded in a commercial face mask for use as an antiviral mask with a pronounced potential to reduce the spreading of infectious respiratory diseases, for example, COVID-19 and its analogues.Entities:
Year: 2022 PMID: 35557678 PMCID: PMC9089365 DOI: 10.1021/acsomega.2c00458
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Scheme 1Preparation of ZnO-NPs, ZnO-NPs@PVDF Nanofibers, and the Antiviral Activity
Image created with BioRender.com.
Figure 1SEM images and EDX analysis of (a) blank PVDF, (b) 2 wt % ZnO/PVDF, (c) 5 wt % ZnO/PVDF composite nanofibers, with the original magnification at 30,000×@10 kV.
Figure 2(a) XRD patterns of pure PVDF and ZnO NP-loaded PVDF NFs, (b) FTIR spectra showing no change in the chemical groups after loading ZnO NPs, indicating no chemical interactions.
Mechanical Measurements of Electrospun PVDF and 2% ZnO/PVDF NFs and 5% ZnO/PVDF NFs
| test | PVDF NFs | 2% ZnO/PVDF NFs | 5% ZnO/PVDF NFs |
|---|---|---|---|
| max. strain | 24 ± 0.5 | 25 ± 0.5 | 30 ± 2.5 |
| max. displacement (mm) | 4.8 | 4.8 | 6.1 |
| Young’s modulus (MPa) | 2501 ± 1.57 | 1998 ± 2.35 | 2633 ± 6.5 |
| tensile strength (MPa) | 55 | 56 | 64 |
| elastic modulus (GPa) | 1.5 ± 0.4 | 1.65 ± 0.52 | 1.95 ± 0.65 |
Stability Tests of 5% ZnO/PVDF NFs
| test | nanofibers after 0 day of fabrication | nanofibers after 5 months of fabrication |
|---|---|---|
| nanofiber color | white | white |
| nanofiber flexibility | flexible | flexible |
| shelf stability | stable at room temp. | stable at room temp. |
| humidity uptake | 0% | 0% |
Humidity uptake after 72 h in a closed system contains 200 mL of H2O.
Figure 3Cell viability (%) by MTT assay of PVDF, 2% ZnO/PVDF NFs, and 5% ZnO/PVDF NFs.
RT-qPCR Assay of ADV-5-Treated Vero Cells with Our Tested Materials
| ADV-5 | CT | copies/mL | CT | copies/mL |
|---|---|---|---|---|
| untreated Vero cells (cell control) | under detection (UD) | UD | UD | UD |
| PVDF NFs | 14.2 | 7.4 × 107 | 25.5 | 1.3 × 103 |
| 2% ZnO/PVDF NFs | 15.9 | 5.9 × 106 | UD | UD |
| 5% ZnO/PVDF NFs | UD | UD | UD | UD |
| VC | 24.4 | 3.3 × 103 | 24.4 | 3.3 × 103 |
| (+ve control) | 22.8 | 2.7 × 104 | 22.8 | 2.7 × 104 |
| (−ve control) | UD | UD | UD | UD |
RT-qPCR assay of ADV-5-treated cells (adsorption).
For the against (virucidal) with the selected nontoxic materials. CT, mean threshold cycle; VC, virus control.
Figure 4Interaction of PVDF with the hexon protein in the predicted binding pocket.
Figure 5Interaction of ZnO@PVDF with the hexon protein in the predicted binding pocket.